Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1998 3
1999 2
2001 1
2002 2
2003 3
2004 1
2005 2
2009 3
2010 1
2011 4
2012 4
2013 7
2014 5
2015 3
2016 9
2017 8
2018 5
2019 5
2020 8
2021 14
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, Smura T, Levanov L, Szirovicza L, Tobi A, Kallio-Kokko H, Österlund P, Joensuu M, Meunier FA, Butcher SJ, Winkler MS, Mollenhauer B, Helenius A, Gokce O, Teesalu T, Hepojoki J, Vapalahti O, Stadelmann C, Balistreri G, Simons M. Cantuti-Castelvetri L, et al. Among authors: teesalu t. Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985. Epub 2020 Oct 20. Science. 2020. PMID: 33082293 Free PMC article.
Neuropilin-1 is a host factor for SARS-CoV-2 infection.
Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Antón-Plágaro C, Shoemark DK, Simón-Gracia L, Bauer M, Hollandi R, Greber UF, Horvath P, Sessions RB, Helenius A, Hiscox JA, Teesalu T, Matthews DA, Davidson AD, Collins BM, Cullen PJ, Yamauchi Y. Daly JL, et al. Among authors: teesalu t. Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072. Epub 2020 Oct 20. Science. 2020. PMID: 33082294
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E. Sugahara KN, et al. Among authors: teesalu t. Cancer Cell. 2009 Dec 8;16(6):510-20. doi: 10.1016/j.ccr.2009.10.013. Cancer Cell. 2009. PMID: 19962669 Free PMC article.
Homing Peptides for Cancer Therapy.
Lingasamy P, Teesalu T. Lingasamy P, et al. Among authors: teesalu t. Adv Exp Med Biol. 2021;1295:29-48. doi: 10.1007/978-3-030-58174-9_2. Adv Exp Med Biol. 2021. PMID: 33543454 Review.
Novel Anthracycline Utorubicin for Cancer Therapy.
Simón-Gracia L, Sidorenko V, Uustare A, Ogibalov I, Tasa A, Tshubrik O, Teesalu T. Simón-Gracia L, et al. Among authors: teesalu t. Angew Chem Int Ed Engl. 2021 Jul 26;60(31):17018-17027. doi: 10.1002/anie.202016421. Epub 2021 Jun 1. Angew Chem Int Ed Engl. 2021. PMID: 33908690 Free PMC article.
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer.
Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN. Hurtado de Mendoza T, et al. Among authors: teesalu t. Nat Commun. 2021 Mar 9;12(1):1541. doi: 10.1038/s41467-021-21858-1. Nat Commun. 2021. PMID: 33750829 Free PMC article.
Tumor-penetrating peptides.
Teesalu T, Sugahara KN, Ruoslahti E. Teesalu T, et al. Front Oncol. 2013 Aug 27;3:216. doi: 10.3389/fonc.2013.00216. eCollection 2013. Front Oncol. 2013. PMID: 23986882 Free PMC article.
LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy.
d'Avanzo N, Torrieri G, Figueiredo P, Celia C, Paolino D, Correia A, Moslova K, Teesalu T, Fresta M, Santos HA. d'Avanzo N, et al. Among authors: teesalu t. Int J Pharm. 2021 Mar 15;597:120346. doi: 10.1016/j.ijpharm.2021.120346. Epub 2021 Feb 2. Int J Pharm. 2021. PMID: 33545283 Free article.
90 results